Healthcare
Spectral AI, Inc.(MDAI)
Live Price
Offline$1.73
-4.95% today
1Y Change
-16.51%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $70.00M
- Revenue Growth
- -33.6%
- EPS Growth
- +65.9%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Spectral AI, Inc. (MDAI) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $1.73 and down 16.5% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of -33.6%, EPS growth of +65.9%, a dividend yield of 0.0%. What stands out right now is revenue -33.6%, EPS +65.9%, free cash flow -7.8% with operating margin -45.5% and ROIC -202.5%. Valuation is more restrained than many high-expectation growth names at price/sales 3.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MDAI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-33.6% vs +7.6% peer median
Operating Margin
Below sector median
-45.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -33.6% and EPS is at +65.9%, with operating margin around -45.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.9% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +4.4% | +19.1% | -8.8% |
2026 Mar 24, 2026 | +8.3% | -6.7% | -10.9% | +11.5% |
2025 Nov 11, 2025 | -52.9% | -7.0% | -16.9% | -1.2% |
Benchmark Edge
MDAI vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MDAI
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MDAI Max Drawdown
-61.78%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MDAI and SPY.
Company Overview
Spectral AI, Inc.
NASDAQ Capital Market
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
- Leadership
- Vincent Stanley Capone
- IPO Date
- Apr 6, 2021
- Employees
- 78
- Street Address
- 2515 McKinney Avenue
- Mailing
- Dallas, TX, 75201
- Region
- Dallas, TX, US
- Reporting Currency
- USD
- Investor Line
- 972-499-4934
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 3.5
- Price/Book
- โ
Growth
- Revenue
- -33.6%
- EPS
- +65.9%
- Free Cash Flow
- -7.8%
Profitability
- Gross Margin
- 44.4%
- Operating Margin
- -45.5%
- Net Margin
- -41.1%
- ROE
- 129.2%
- ROIC
- -202.5%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.94
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.